Insulet | PODD - Market Capitalization

Stock Price
224.66
Daily Change
4.82 2.19%
Monthly
-8.80%
Yearly
-14.13%
Q1 Forecast
213.20

Insulet reported $15.97B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Align Technology USD 11.2B 2.13B Dec/2025
AtriCure USD 1.97B 215M Dec/2025
Avanos Medical USD 648M 127M Mar/2026
Baxter International USD 9.82B 1.87B Dec/2025
Becton, Dickinson and Co. USD 55.29B 1.64B Dec/2025
Boston Scientific USD 141.35B 3.31B Dec/2025
Cardinal Health USD 48.83B 11.54B Dec/2025
Cooper Companies USD 14.7B 1.24B Mar/2026
Dexcom USD 25.88B 503M Dec/2025
Edwards Lifesciences USD 49.47B 3.81B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Globus Medical USD 12.64B 954M Mar/2026
ICU Medical USD 3.52B 561M Dec/2025
Insulet USD 20B 1.74B Dec/2025
Integra LifeSciences USD 967M 150M Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Masimo USD 9.28B 2.44B Mar/2026
Merit Medical Systems USD 5.23B 297M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Stryker USD 134.41B 6.92B Dec/2025
Tandem Diabetes Care USD 1.49B 670M Dec/2025
Teleflex USD 5.39B 91M Dec/2025
West Pharmaceutical Services USD 19.8B 932M Dec/2025
WK Kellogg Co USD 13.74B 1.09B Dec/2025
Zimmer Biomet Holdings USD 17.82B 1.69B Dec/2025